Doctor profile · Federal record
Dr. LARRY MOORE, M.D.
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Interventional Cardiology Physician · MESQUITE, TX
- NPI 1770553174
- 46 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
5308 NORTH GALLOWAY AVE, SUITE 100
MESQUITE, TX 75150
(972) 226-0505
fax (972) 289-9640 - Mailing address
-
5308 N GALLOWAY AVE, SUITE 100
MESQUITE, TX 751501122
Credentials & registration
- NPI registered
- January 2006 — 20 yrs on file
- Profile last updated
- April 1, 2008
- Year of graduation
- 1980 — 46 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Texas #F6970
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1770553174. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,695
Distinct HCPCS
10
Medicare allowed
$156,211
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 408 | 222 | $120 | |
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 364 | 215 | $14 | |
J2785 |
Injection, regadenoson, 0.1 mg | 140 | 35 | $54 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 103 | 101 | $179 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 99 | 41 | $112 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 68 | 22 | $22 | |
93015 |
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 66 | 66 | $60 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 62 | 55 | $85 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 57 | 19 | $28 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 53 | 52 | $64 |
In context: peer comparison
Among 3 peers in this city , average services per provider: 106. This provider delivers 16× the peer median.Open Payments
Industry payments received
All-time total
$2,137
Transactions
72
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| BIOTRONIK INC. | 20 | $791.81 | |
| Novartis Pharmaceuticals Corporation | 8 | $218.23 | |
| SCPHARMACEUTICALS INC. | 8 | $152.87 | |
| Abbott Laboratories | 2 | $136.60 | |
| AstraZeneca Pharmaceuticals LP | 5 | $105.58 | |
| Merck Sharp & Dohme LLC | 5 | $104.58 | |
| Amgen Inc. | 5 | $101.66 | |
| E.R. Squibb & Sons, L.L.C. | 4 | $90.65 | |
| PFIZER INC. | 3 | $61.07 | |
| Lexicon Pharmaceuticals, Inc. | 3 | $58.40 | |
| Esperion Therapeutics, Inc. | 3 | $52.27 | |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $49.66 | |
| Novo Nordisk Inc | 2 | $49.02 | |
| ABIOMED | 1 | $38.57 | |
| Impulse Dynamics (USA) Inc. | 1 | $33.12 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,337
Patients
783
Total drug cost
$562,639
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 377 | 98 | $441,178 |
| Metoprolol Succinate | Generic | 299 | 103 | $5,989 |
| Atorvastatin Calcium | Generic | 248 | 91 | $3,150 |
| Amlodipine Besylate | Generic | 177 | 63 | $1,532 |
| Carvedilol | Generic | 172 | 53 | $2,044 |
| Metoprolol Tartrate | Generic | 169 | 61 | $1,549 |
| Furosemide | Generic | 160 | 59 | $888 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 121 | 42 | $1,646 |
| Losartan Potassium | Generic | 107 | 41 | $1,324 |
| Ezetimibe | Generic | 99 | 37 | $3,859 |